7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 
      
    		                                  
      cash flows from operating activities
    		                                  
      net income
    		912,000,000 1,060,000,000 583,000,000 511,000,000 829,000,000 990,000,000 377,000,000 872,000,000 890,000,000 417,000,000 494,000,000 548,000,000 756,000,000 761,000,000 701,000,000 1,031,000,000 591,000,000 437,000,000 177,000,000 -140,000,000 335,000,000 364,000,000 380,000,000 352,000,000 476,000,000 479,000,000 515,000,000 380,000,000 449,000,000 281,000,000 365,000,000 151,000,000 170,000,000 248,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                  
      depreciation, amortization and accretion
    		-19,000,000 -27,000,000 -27,000,000 -36,000,000 -47,000,000 -42,000,000 -40,000,000 -44,000,000 -35,000,000 -35,000,000 -29,000,000 -7,000,000 8,000,000 -12,000,000 3,000,000 -25,000,000 60,000,000 60,000,000 57,000,000 54,000,000 62,000,000 65,000,000 63,000,000 62,000,000 57,000,000 66,000,000 63,000,000 64,000,000 59,000,000 58,000,000 58,000,000 58,000,000 54,000,000 56,000,000 
      deferred income tax expense
    		80,000,000 202,000,000 -95,000,000 -89,000,000 31,000,000 227,000,000 -88,000,000 46,000,000 108,000,000 -48,000,000 -181,000,000 24,000,000 -1,000,000 154,000,000 -150,000,000 -98,000,000 101,000,000 60,000,000 -519,000,000 -323,000,000 -90,000,000 36,000,000   22,000,000 66,000,000 -37,000,000   -23,000,000 41,000,000    
      share-based compensation
    		50,000,000 46,000,000 49,000,000 48,000,000 48,000,000 42,000,000 49,000,000 46,000,000 46,000,000 46,000,000 43,000,000 41,000,000 42,000,000 44,000,000 28,000,000 50,000,000 39,000,000 35,000,000 39,000,000 35,000,000 34,000,000 34,000,000 37,000,000 38,000,000 35,000,000 35,000,000 30,000,000 37,000,000 35,000,000 38,000,000 33,000,000 32,000,000 34,000,000 32,000,000 
      net realized investment (gains) losses
    		-11,000,000 15,000,000 -5,000,000  -1,000,000 -1,000,000 0    4,000,000    -5,000,000 -548,000,000 -14,000,000 -65,000,000 -8,000,000 -4,000,000               
      net trading (gains) losses
    		-2,000,000 -1,000,000 -1,000,000 -1,000,000 -2,000,000 -2,000,000 -3,000,000 13,000,000 -10,000,000 -9,000,000 8,000,000 5,000,000   2,000,000 0 2,000,000 1,000,000 -1,000,000 -3,000,000               
      income from equity method investments
    		-6,000,000 -4,000,000 13,000,000 -2,000,000 11,000,000 4,000,000 8,000,000 2,000,000 6,000,000 11,000,000 11,000,000 7,000,000 6,000,000 12,000,000 17,000,000 25,000,000 21,000,000 12,000,000 8,000,000 19,000,000 11,000,000 9,000,000  8,000,000 9,000,000 5,000,000      0   
      impairments and benefit from loan and credit losses
    		11,000,000 1,000,000 -5,000,000   -1,000,000 -1,000,000 -6,000,000 -14,000,000 5,000,000 5,000,000 84,000,000                       
      net (gains) losses of consolidated investment entities
    		-3,000,000 -5,000,000 12,000,000 3,000,000 -1,000,000 3,000,000 5,000,000 5,000,000 7,000,000 6,000,000 12,000,000 1,000,000 1,000,000 3,000,000 -3,000,000 3,000,000 -1,000,000 -19,000,000 14,000,000 -20,000,000               
      changes in operating assets and liabilities:
    		                                  
      restricted and segregated investments
    		0 319,000,000 158,000,000 -184,000,000 340,000,000 -158,000,000 99,000,000 -320,000,000 336,000,000 -123,000,000 150,000,000 -48,000,000 -74,000,000 -124,000,000 126,000,000 164,000,000 50,000,000 -315,000,000                 
      deferred acquisition costs
    		13,000,000 14,000,000 16,000,000 8,000,000 7,000,000 12,000,000 12,000,000 12,000,000 17,000,000 23,000,000 -193,000,000 61,000,000 100,000,000 43,000,000 -28,000,000 -58,000,000 -10,000,000 -60,000,000 -138,000,000 31,000,000 3,000,000 28,000,000 -45,000,000 41,000,000 2,000,000 -5,000,000 8,000,000 -34,000,000       
      policyholder account balances, future policy benefits and claims, and market risk benefits
    		1,603,000,000 1,238,000,000 940,000,000 1,837,000,000 1,160,000,000 448,000,000 1,840,000,000 78,000,000 80,000,000 1,073,000,000                         
      derivatives, net of collateral
    		-572,000,000 -545,000,000 270,000,000 -397,000,000 -720,000,000 -51,000,000 -193,000,000 76,000,000 -265,000,000 -242,000,000 -150,000,000 506,000,000 -37,000,000 -4,000,000 -280,000,000 -168,000,000 -266,000,000 144,000,000 -406,000,000 532,000,000 -278,000,000 -382,000,000 273,000,000 -436,000,000 521,000,000 -265,000,000 -85,000,000 612,000,000 378,000,000      
      receivables
    		-348,000,000 117,000,000 -220,000,000 266,000,000   -48,000,000 -155,000,000 223,000,000 256,000,000 176,000,000 79,000,000 -128,000,000 -83,000,000 -160,000,000 -124,000,000 2,000,000 -238,000,000 -432,000,000 -85,000,000 36,000,000 -62,000,000 17,000,000 -16,000,000 -94,000,000 -184,000,000 -144,000,000 -129,000,000       
      brokerage deposits
    		-69,000,000 -121,000,000 -25,000,000 357,000,000 -202,000,000 90,000,000 -166,000,000 -51,000,000 -250,000,000 -314,000,000 -177,000,000 -196,000,000 -92,000,000 120,000,000 71,000,000 59,000,000 -2,000,000 -102,000,000 141,000,000 13,000,000 39,000,000 -108,000,000 286,000,000 46,000,000 -105,000,000 110,000,000 60,000,000 220,000,000      23,000,000 
      accounts payable and accrued expenses
    		246,000,000 179,000,000 -452,000,000 189,000,000 220,000,000 -436,000,000 290,000,000 117,000,000 166,000,000 -219,000,000 195,000,000 -181,000,000 228,000,000 -461,000,000 154,000,000 -7,000,000 316,000,000 -163,000,000 223,000,000 111,000,000 99,000,000 -295,000,000 123,000,000 103,000,000 52,000,000 -196,000,000 -183,000,000 72,000,000       
      current income tax
    		137,000,000 -593,000,000 180,000,000 97,000,000 121,000,000 -44,000,000 -49,000,000 67,000,000 -485,000,000 80,000,000 177,000,000 -102,000,000 68,000,000 -27,000,000                     
      other operating assets and liabilities of consolidated investment entities
    		-2,000,000 5,000,000 2,000,000 4,000,000 -2,000,000 -1,000,000 3,000,000 0 -2,000,000 -6,000,000 1,000,000 -1,000,000 -6,000,000 8,000,000 5,000,000 7,000,000 4,000,000 4,000,000 -35,000,000 26,000,000 2,000,000 -12,000,000 41,000,000 10,000,000 48,000,000 -4,000,000 -14,000,000 8,000,000 -57,000,000   -1,000,000   
      other
    		184,000,000 -136,000,000 293,000,000 430,000,000 -28,000,000 364,000,000 49,000,000 123,000,000 -261,000,000 135,000,000 -2,000,000 -58,000,000 192,000,000 159,000,000 -45,000,000 -353,000,000 177,000,000 284,000,000 98,000,000 -122,000,000 45,000,000 207,000,000 -226,000,000 66,000,000 27,000,000 544,000,000 259,000,000 -123,000,000 112,000,000 -62,000,000 74,000,000 87,000,000 -120,000,000 404,000,000 
      net cash from operating activities
    		2,204,000,000 1,764,000,000 1,686,000,000 3,048,000,000 1,720,000,000 1,444,000,000 2,143,000,000 925,000,000 561,000,000 1,056,000,000 1,217,000,000 1,372,000,000 1,409,000,000 409,000,000 1,551,000,000 843,000,000 1,931,000,000 -1,000,000,000 -1,016,000,000 936,000,000 724,000,000 621,000,000 669,000,000 371,000,000 619,000,000 913,000,000 434,000,000 258,000,000    415,000,000 293,000,000 175,000,000 
      cash flows from investing activities
    		                                  
      available-for-sale securities:
    		                                  
      proceeds from sales
    		328,000,000 498,000,000 1,075,000,000 1,779,000,000   8,000,000 397,000,000 16,000,000 313,000,000 568,000,000 436,000,000   1,000,000 150,000,000 313,000,000 92,000,000 18,000,000 372,000,000 160,000,000 154,000,000 143,000,000 95,000,000 8,000,000 48,000,000 161,000,000 0 58,000,000 100,000,000 169,000,000 450,000,000 50,000,000 100,000,000 
      maturities, sinking fund payments and calls
    		4,551,000,000 4,262,000,000 4,221,000,000 3,981,000,000 3,872,000,000 3,283,000,000 2,570,000,000 2,229,000,000 2,967,000,000 1,464,000,000 1,772,000,000 1,859,000,000 1,781,000,000 2,209,000,000 2,509,000,000 3,278,000,000 2,750,000,000 2,964,000,000 2,986,000,000 2,406,000,000 1,428,000,000 956,000,000 1,089,000,000 954,000,000 1,148,000,000 1,351,000,000 1,104,000,000 1,275,000,000 1,371,000,000 1,206,000,000 1,249,000,000 1,333,000,000 1,161,000,000 1,174,000,000 
      purchases
    		-3,656,000,000 -3,808,000,000 -6,834,000,000 -5,007,000,000 -3,647,000,000 -3,972,000,000 -4,500,000,000 -4,096,000,000 -6,000,000,000 -5,098,000,000 -6,582,000,000 -6,531,000,000 -4,949,000,000 -3,972,000,000 -4,671,000,000 -3,837,000,000 -2,965,000,000 -3,245,000,000 -3,328,000,000 -4,059,000,000 -1,744,000,000 -1,366,000,000 -1,222,000,000 -1,002,000,000 -1,131,000,000 -1,207,000,000 -1,029,000,000 -1,686,000,000       
      proceeds from sales, maturities and repayments of mortgage loans
    		67,000,000 49,000,000 37,000,000 38,000,000 58,000,000 32,000,000 44,000,000 33,000,000 34,000,000 41,000,000 58,000,000 40,000,000 39,000,000 32,000,000 57,000,000 69,000,000 118,000,000 55,000,000 71,000,000 54,000,000 147,000,000 410,000,000             
      funding of mortgage loans
    		-210,000,000 -133,000,000 -107,000,000 -104,000,000 -136,000,000 -69,000,000 -97,000,000 -64,000,000 -71,000,000 -52,000,000  -31,000,000 -65,000,000 -51,000,000 -97,000,000 -46,000,000 -98,000,000 -22,000,000 -18,000,000 -15,000,000 -109,000,000 -119,000,000 -131,000,000 -159,000,000 -177,000,000 -91,000,000 -124,000,000        
      proceeds from sales, maturities and collections of other investments
    		10,000,000 29,000,000 22,000,000 35,000,000 47,000,000 20,000,000 30,000,000 55,000,000 29,000,000 31,000,000 48,000,000 15,000,000 18,000,000 15,000,000 18,000,000 43,000,000 58,000,000 54,000,000 59,000,000 30,000,000               
      purchase of other investments
    		-6,000,000 -15,000,000 -26,000,000 -21,000,000 -109,000,000 -23,000,000 -43,000,000 -33,000,000 -16,000,000 -24,000,000 -24,000,000 -14,000,000 -56,000,000 -5,000,000 -24,000,000 -19,000,000 -23,000,000 -31,000,000 -65,000,000 -85,000,000 -40,000,000 -46,000,000 -57,000,000 -107,000,000 -49,000,000 -93,000,000 -111,000,000 -80,000,000       
      purchase of investments by consolidated investment entities
    		-333,000,000 -377,000,000 -354,000,000 -345,000,000 -315,000,000 -131,000,000 -80,000,000 -92,000,000 -133,000,000 -122,000,000 -198,000,000 -396,000,000 -177,000,000 -190,000,000 -142,000,000 -283,000,000 -441,000,000 -737,000,000 -278,000,000 -303,000,000 -158,000,000 -158,000,000 -615,000,000 -820,000,000 -840,000,000 -403,000,000 -742,000,000 -640,000,000       
      proceeds from sales, maturities and repayments of investments by consolidated investment entities
    		237,000,000 259,000,000 167,000,000 214,000,000 250,000,000 236,000,000 151,000,000 144,000,000 166,000,000 182,000,000 149,000,000 154,000,000 129,000,000 183,000,000 197,000,000 294,000,000 316,000,000 240,000,000 152,000,000 111,000,000 275,000,000 182,000,000 580,000,000 570,000,000 463,000,000 396,000,000 418,000,000 389,000,000 378,000,000 1,147,000,000 690,000,000 469,000,000 682,000,000 468,000,000 
      purchase of land, buildings, equipment and software
    		-44,000,000 -38,000,000 -36,000,000 -49,000,000 -17,000,000 -52,000,000 -50,000,000 -50,000,000 -43,000,000 -41,000,000 -56,000,000 -42,000,000 -40,000,000 -44,000,000 -34,000,000 -31,000,000 -33,000,000 -22,000,000 -40,000,000 -45,000,000 -8,000,000 -28,000,000 -24,000,000 -42,000,000 -38,000,000 -29,000,000 -20,000,000 -37,000,000       
      cash paid for written options with deferred premiums
    		   0 0 -57,000,000 0 0 0 -59,000,000 -208,000,000 -291,000,000   -238,000,000 -104,000,000 1,000,000 -211,000,000 -46,000,000 -34,000,000               
      cash received from written options with deferred premiums
    		0   0 7,000,000 15,000,000 0 12,000,000 7,000,000 24,000,000 63,000,000 54,000,000 75,000,000 12,000,000 46,000,000 36,000,000 3,000,000 21,000,000 4,000,000 21,000,000               
      cash paid for deposit receivables
    		-7,000,000 -7,000,000 -8,000,000 -8,000,000 -8,000,000 -9,000,000 -9,000,000 -10,000,000 -10,000,000 -10,000,000 -11,000,000 -11,000,000 -11,000,000 -12,000,000                     
      cash received for deposit receivables
    		101,000,000 117,000,000 112,000,000 143,000,000 160,000,000 167,000,000 195,000,000 172,000,000 197,000,000 210,000,000 157,000,000 130,000,000 129,000,000 134,000,000                     
      net cash from investing activities
    		1,004,000,000 802,000,000 -1,741,000,000 635,000,000 166,000,000 -569,000,000 -1,920,000,000 -1,322,000,000 -2,874,000,000 -3,146,000,000 -4,342,000,000 -4,649,000,000 -2,927,000,000 -1,665,000,000 -3,007,000,000 -464,000,000 -100,000,000 -809,000,000 -473,000,000 -1,525,000,000 61,000,000 2,000,000 -67,000,000 -265,000,000 -364,000,000 182,000,000 -145,000,000 -659,000,000 -833,000,000 301,000,000 389,000,000 940,000,000   
      see notes to consolidated financial statements.
    		                                  
      consolidated statements of cash flows
    		                                  
      cash flows from financing activities
    		                                  
      investment certificates:
    		                                  
      proceeds from additions
    		695,000,000 791,000,000 961,000,000 1,032,000,000 1,213,000,000 1,638,000,000 2,621,000,000 2,177,000,000 2,805,000,000 3,590,000,000 4,499,000,000 2,009,000,000 1,102,000,000 733,000,000 729,000,000 607,000,000 674,000,000 723,000,000 831,000,000 894,000,000 1,009,000,000 1,159,000,000 957,000,000 807,000,000 713,000,000 662,000,000 617,000,000 624,000,000 619,000,000 516,000,000 589,000,000 539,000,000 242,000,000 185,000,000 
      maturities, withdrawals and cash surrenders
    		-1,652,000,000 -1,584,000,000 -1,471,000,000 -1,560,000,000 -1,912,000,000 -1,881,000,000 -1,760,000,000 -1,637,000,000 -1,820,000,000 -1,822,000,000 -1,397,000,000 -1,092,000,000 -1,015,000,000 -835,000,000 -870,000,000 -913,000,000 -1,183,000,000 -1,224,000,000 -1,236,000,000 -1,181,000,000 -790,000,000 -807,000,000 -656,000,000 -626,000,000 -668,000,000 -559,000,000 -528,000,000 -528,000,000       
      policyholder account balances:
    		                                  
      deposits and other additions
    		377,000,000 336,000,000 254,000,000 345,000,000 391,000,000 358,000,000 443,000,000 304,000,000 390,000,000 339,000,000 403,000,000 279,000,000 202,000,000 285,000,000 422,000,000 380,000,000 367,000,000 384,000,000 447,000,000 428,000,000 518,000,000 481,000,000 547,000,000 530,000,000 514,000,000 470,000,000 494,000,000        
      net transfers from (to) separate accounts
    		-47,000,000 -35,000,000 -36,000,000 -53,000,000 -45,000,000 -26,000,000 -43,000,000 -34,000,000 -36,000,000 -19,000,000 -34,000,000 -38,000,000 -33,000,000 -57,000,000 -67,000,000 -74,000,000 -72,000,000 -60,000,000 -62,000,000 -48,000,000 50,000,000 33,000,000             
      surrenders and other benefits
    		-359,000,000 -356,000,000 -395,000,000 -425,000,000 -465,000,000 -495,000,000 -563,000,000 -479,000,000 -491,000,000 -569,000,000 -470,000,000 -340,000,000 -321,000,000 -328,000,000 -363,000,000 -309,000,000 -325,000,000 -368,000,000 -322,000,000 -309,000,000 -492,000,000 -497,000,000 -545,000,000 -603,000,000 -778,000,000 -788,000,000 -661,000,000 -1,084,000,000       
      change in banking deposits
    		95,000,000 -172,000,000 363,000,000 265,000,000 138,000,000 -170,000,000 527,000,000 38,000,000 926,000,000 1,702,000,000 -288,000,000 3,072,000,000 2,299,000,000 1,802,000,000 1,604,000,000 1,144,000,000 688,000,000 580,000,000 1,084,000,000 1,022,000,000               
      cash paid for purchased options with deferred premiums
    		-31,000,000 -37,000,000 -3,000,000 -43,000,000 -28,000,000 -51,000,000 -4,000,000 -5,000,000 -20,000,000 -24,000,000 -38,000,000 -42,000,000 -46,000,000 -71,000,000 -62,000,000 -18,000,000 -34,000,000 -42,000,000 -34,000,000 -46,000,000 -78,000,000 -85,000,000 -87,000,000 -89,000,000 -127,000,000 -89,000,000 -124,000,000 -106,000,000       
      cash received for purchased options with deferred premiums
    		   99,000,000                               
      issuance of long-term debt, net of issuance costs
    		0 0 740,000,000    594,000,000 0 0 741,000,000                         
      repayments of long-term debt
    		-2,000,000 -503,000,000 -3,000,000 -3,000,000 -2,000,000 -3,000,000 -752,000,000 -3,000,000 -3,000,000 -2,000,000 -3,000,000 -2,000,000 -3,000,000 -502,000,000 -3,000,000 -2,000,000 -2,000,000 -2,000,000 -2,000,000 -4,000,000 -232,000,000 -19,000,000             
      dividends paid to shareholders
    		-151,000,000 -152,000,000 -144,000,000 -145,000,000 -147,000,000 -138,000,000 -136,000,000 -139,000,000 -141,000,000 -134,000,000 -133,000,000 -135,000,000 -137,000,000 -129,000,000 -127,000,000 -129,000,000 -126,000,000 -129,000,000 -122,000,000 -125,000,000 -124,000,000 -115,000,000 -117,000,000 -119,000,000 -122,000,000 -107,000,000 -100,000,000 -101,000,000       
      repurchase of common shares
    		-701,000,000 -581,000,000 -730,000,000 -582,000,000 -573,000,000 -628,000,000 -467,000,000 -545,000,000 -498,000,000 -617,000,000 -488,000,000 -501,000,000 -448,000,000 -541,000,000 -563,000,000 -556,000,000 -441,000,000 -470,000,000 -405,000,000 -320,000,000 -420,000,000 -481,000,000 -448,000,000 -467,000,000 -432,000,000 -394,000,000 -457,000,000 -378,000,000       
      borrowings of consolidated investment entities
    		126,000,000 387,000,000 304,000,000 329,000,000 388,000,000 166,000,000     0                        
      repayments of debt by consolidated investment entities
    		-256,000,000 -34,000,000 -328,000,000 -434,000,000 -117,000,000 -227,000,000 -78,000,000 -102,000,000 -64,000,000 -31,000,000 -3,000,000 0 0 -1,000,000 -385,000,000 -3,000,000 -691,000,000 -63,000,000 -19,000,000 -18,000,000 -34,000,000 -26,000,000 -314,000,000 -144,000,000 -69,000,000 -192,000,000 -85,000,000 -77,000,000       
      net cash from financing activities
    		-1,858,000,000 -1,940,000,000 -488,000,000 -1,173,000,000 -1,103,000,000 -1,431,000,000 381,000,000 -322,000,000 1,190,000,000 3,162,000,000 2,217,000,000 3,606,000,000 2,089,000,000 518,000,000 1,464,000,000 360,000,000 -534,000,000 433,000,000 159,000,000 676,000,000 -589,000,000 -319,000,000 -1,016,000,000 119,000,000 -516,000,000 -905,000,000 -521,000,000 -99,000,000       
      effect of exchange rate changes on cash
    		-8,000,000 25,000,000 13,000,000 26,000,000 1,000,000 -5,000,000 25,000,000 -22,000,000 17,000,000 11,000,000 48,000,000 -96,000,000 0 -20,000,000 7,000,000 -18,000,000 0 9,000,000 14,000,000 13,000,000 -26,000,000 -12,000,000 -9,000,000 -15,000,000 22,000,000 -19,000,000 3,000,000 7,000,000    7,000,000 -5,000,000 7,000,000 
      net increase in cash and cash equivalents, including amounts restricted
    		1,342,000,000 651,000,000 -530,000,000 2,536,000,000 784,000,000 -561,000,000 629,000,000 -741,000,000 -1,106,000,000 1,083,000,000 -860,000,000 233,000,000 571,000,000 -758,000,000 15,000,000 721,000,000 1,297,000,000 -1,367,000,000 -1,316,000,000 100,000,000               
      cash and cash equivalents, including amounts restricted at beginning of period
    		0 0 9,489,000,000                                
      cash and cash equivalents, including amounts restricted at end of period
    		1,342,000,000 651,000,000 8,959,000,000                                
      supplemental disclosures:
    		                                  
      interest paid excluding consolidated investment entities
    		122,000,000 175,000,000 131,000,000 175,000,000 244,000,000 195,000,000 244,000,000 157,000,000 169,000,000 112,000,000 63,000,000 35,000,000 27,000,000 27,000,000 28,000,000 27,000,000 28,000,000 30,000,000 32,000,000 36,000,000 52,000,000 28,000,000 64,000,000 27,000,000 67,000,000 28,000,000 32,000,000        
      interest paid by consolidated investment entities
    		48,000,000 35,000,000 39,000,000 40,000,000 42,000,000 44,000,000 45,000,000 45,000,000 43,000,000 44,000,000 26,000,000 19,000,000 17,000,000 13,000,000 17,000,000 43,000,000 19,000,000 11,000,000 10,000,000 12,000,000 25,000,000 25,000,000 82,000,000 61,000,000 60,000,000 54,000,000         
      income taxes paid
    		29,000,000 672,000,000 28,000,000 108,000,000 82,000,000 25,000,000 240,000,000 112,000,000 651,000,000 33,000,000 133,000,000 201,000,000 132,000,000 34,000,000 119,000,000 229,000,000 602,000,000 36,000,000 120,000,000 65,000,000 152,000,000 23,000,000 194,000,000 165,000,000 59,000,000 21,000,000 50,000,000 209,000,000 89,000,000   43,000,000   
      leased assets obtained in exchange for operating lease liabilities
    		8,000,000 12,000,000 22,000,000 8,000,000 4,000,000 11,000,000 9,000,000 48,000,000 3,000,000 7,000,000 5,000,000 15,000,000 14,000,000 13,000,000 46,000,000 11,000,000 8,000,000 44,000,000 8,000,000 17,000,000               
      reconciliation of cash and cash equivalents, including amounts restricted:
    		                                  
      cash and cash equivalents
    		1,612,000,000 156,000,000 7,806,000,000 3,058,000,000 446,000,000 7,071,000,000  -333,000,000 -1,043,000,000 8,386,000,000  330,000,000 866,000,000 6,623,000,000  615,000,000 1,659,000,000 5,462,000,000  -213,000,000               
      cash of consolidated investment entities
    		-231,000,000 251,000,000 168,000,000 -227,000,000 216,000,000 135,000,000  -44,000,000 -27,000,000 162,000,000  102,000,000 -47,000,000 119,000,000  -27,000,000 -230,000,000 325,000,000  178,000,000               
      restricted and segregated cash, cash equivalents and investments
    		-39,000,000 -75,000,000 1,304,000,000 -112,000,000 -218,000,000 1,591,000,000  -43,000,000 -372,000,000 1,984,000,000  -151,000,000 -174,000,000 2,668,000,000  -31,000,000 -182,000,000 2,564,000,000  135,000,000               
      less: restricted and segregated investments
    		  -319,000,000 -183,000,000 340,000,000 -738,000,000  -321,000,000 336,000,000 -694,000,000  -48,000,000 -74,000,000 -599,000,000  164,000,000 50,000,000 -815,000,000                 
      total cash and cash equivalents, including amounts restricted per consolidated statements of cash flows
    		1,342,000,000 651,000,000 8,959,000,000                                
      cash and cash equivalents, including amounts restricted, at beginning of period
    		   0 0 8,620,000,000  0 0 8,755,000,000  0 0 9,569,000,000  0 0 8,903,000,000  0               
      cash and cash equivalents, including amounts restricted, at end of period
    		   2,536,000,000 784,000,000 8,059,000,000  -741,000,000 -1,106,000,000 9,838,000,000  233,000,000 571,000,000 8,811,000,000  721,000,000 1,297,000,000 7,536,000,000  100,000,000               
      total cash and cash equivalents including amounts restricted per consolidated statements of cash flows
    		   2,536,000,000 784,000,000 8,059,000,000  -741,000,000 -1,106,000,000 9,838,000,000  233,000,000 571,000,000 8,811,000,000  721,000,000 1,297,000,000 7,536,000,000  100,000,000               
      cash received from purchased options with deferred premiums
    		     26,000,000 0 101,000,000 142,000,000 8,000,000 148,000,000 62,000,000 0 168,000,000 770,000,000 238,000,000 36,000,000 306,000,000 0 1,000,000 0 33,000,000 8,000,000 0   47,000,000        
      changes in operating assets and liabilities
    		                                  
      cash returned (paid) for acquisition of business, net of cash acquired
    		          0 0                       
      exercise of stock options
    		                  1,000,000 0 2,000,000 2,000,000 2,000,000 3,000,000 5,000,000 6,000,000 11,000,000 18,000,000 26,000,000 26,000,000 48,000,000 32,000,000 5,000,000 40,000,000 
      leased assets obtained in exchange for finance lease liabilities
    		                                  
      non-cash investing activities:
    		                                  
      investments transferred in connection with fixed annuity reinsurance transaction
    		                                  
      exchange of an investment that resulted in a realized gain and an increase to amortized cost
    		              0 0 0 17,000,000                 
      deferred taxes
    		       -1,000,000 -5,000,000 7,000,000 -6,000,000 4,000,000 4,000,000 2,000,000 116,000,000 200,000,000 -197,000,000 -115,000,000                 
      net realized investment gains
    		        9,000,000 -7,000,000   9,000,000 -18,000,000         0 3,000,000 -5,000,000 -12,000,000 -6,000,000        
      policyholder account balances, future policy benefits and claims
    		          679,000,000 601,000,000 321,000,000 -168,000,000 912,000,000 797,000,000 1,427,000,000 -1,050,000,000 -198,000,000 531,000,000 492,000,000 669,000,000 -187,000,000 864,000,000 -602,000,000 419,000,000 121,000,000 -294,000,000       
      funding and purchases of mortgage loans
    		                                  
      issuance of long-term debt
    		           0    0 0 4,000,000  -2,000,000               
      non-cash investing activity:
    		                                  
      investments transferred in connection with reinsurance transaction
    		                                  
      gain on disposal of business before affinity partner payment
    		                                  
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                                  
      proceeds from disposal of business, net of cash and cash equivalents sold
    		                                  
      cash paid for acquisition of business, net of cash acquired
    		                                  
      partnership commitments not yet remitted
    		                   2,000,000               
      impairments and benefit from loan losses
    		               -5,000,000    -1,000,000               
      current income tax expense
    		               -107,000,000 -376,000,000 90,000,000 125,000,000 282,000,000               
      cash paid for deposit receivable
    		               -212,000,000 -2,000,000 -2,000,000 -1,000,000 -2,000,000               
      cash received for deposit receivable
    		               88,000,000 23,000,000 21,000,000 19,000,000 21,000,000               
      borrowings by consolidated investment entities
    		               0 578,000,000 797,000,000     67,000,000 815,000,000 569,000,000 199,000,000 478,000,000 538,000,000 133,000,000 587,000,000 467,000,000 92,000,000 79,000,000 4,000,000 
      net increase in cash and cash equivalents, including amounts restricted and cash balances classified as assets held-for-sale
    		                   100,000,000               
      less: net change in cash balances classified as assets held for sale
    		                                  
      net realized investment losses
    		                    -6,000,000 12,000,000             
      net trading gains
    		                    -2,000,000 -2,000,000 -2,000,000 -1,000,000 -1,000,000 -3,000,000 -2,000,000        
      other-than-temporary impairments and benefit from loan losses
    		                      0 7,000,000 0 2,000,000 1,000,000 1,000,000 2,000,000 2,000,000 3,000,000 16,000,000 10,000,000 7,000,000 
      net incomees of consolidated investment entities
    		                                  
      other investments
    		                    -8,000,000 -4,000,000 20,000,000 8,000,000 108,000,000 -55,000,000  -4,000,000 -3,000,000   4,000,000   
      proceeds from sales and collections of other investments
    		                    53,000,000 32,000,000 38,000,000 87,000,000 70,000,000 41,000,000 57,000,000        
      net increase in cash, cash equivalents and restricted cash
    		                                  
      cash, cash equivalents and restricted cash at beginning of period
    		                                  
      net cash outflows upon the deconsolidation of vies
    		                                  
      cash, cash equivalents and restricted cash at end of period
    		                                  
      reconciliation of cash, cash equivalents and restricted cash:
    		                                  
      restricted and segregated cash and investments
    		                    34,000,000 49,000,000 -247,000,000 -211,000,000 222,000,000 -99,000,000 -31,000,000 -100,000,000 -22,000,000 -49,000,000 264,000,000    
      total cash, cash equivalents and restricted cash per consolidated statements of cash flows
    		                                  
      net incomees (gains) of consolidated investment entities
    		                    1,000,000 4,000,000      -73,000,000       
      cash held by consolidated investment entities
    		                    -85,000,000 9,000,000 287,000,000 -315,000,000 -131,000,000 52,000,000 -72,000,000 -75,000,000       
      investment properties of consolidated investment entities
    		                      12,000,000 -187,000,000 94,000,000 -33,000,000 49,000,000 -246,000,000       
      excess tax benefits from share-based compensation
    		                    2,000,000 3,000,000 11,000,000 16,000,000 9,000,000 45,000,000 92,000,000 19,000,000 24,000,000 26,000,000 51,000,000 13,000,000 13,000,000 15,000,000 
      noncontrolling interests investments in subsidiaries
    		                      30,000,000 90,000,000 18,000,000 117,000,000  102,000,000 209,000,000 5,000,000 76,000,000 61,000,000 58,000,000 4,000,000 
      distributions to noncontrolling interests
    		                      -73,000,000 -13,000,000 -110,000,000 -219,000,000 -49,000,000 -19,000,000       
      net increase in cash and cash equivalents
    		                    170,000,000 292,000,000 -423,000,000   171,000,000  -493,000,000       
      cash and cash equivalents at beginning of period
    		                    0 2,357,000,000 0 0 0 2,638,000,000 2,632,000,000 0 0 0 2,371,000,000 0 0 2,781,000,000 
      cash and cash equivalents at end of period
    		                    170,000,000 2,649,000,000 -423,000,000 210,000,000 -239,000,000 2,809,000,000 2,403,000,000 -493,000,000 794,000,000 171,000,000 2,160,000,000 604,000,000 409,000,000 2,312,000,000 
      affordable housing partnership commitments not yet remitted
    		                    9,000,000 10,000,000 36,000,000 0 -1,000,000 10,000,000  70,000,000 -2,000,000 18,000,000 10,000,000 -6,000,000   
      loss (income) from equity method investments
    		                          3,000,000        
      net gains of consolidated investment entities
    		                      -47,000,000   -9,000,000 -101,000,000        
      net transfers to separate accounts
    		                      -30,000,000 -39,000,000 -46,000,000 -56,000,000 -56,000,000        
      change in short-term borrowings
    		                          -200,000,000 0       
      deferred income tax benefit
    		                                  
      proceeds from maturities and repayments of mortgage loans
    		                       162,000,000 156,000,000 163,000,000 140,000,000        
      issuance of debt, net of issuance costs
    		                           151,000,000       
      repayments of debt
    		                                  
      net decrease in cash and cash equivalents
    		                          -229,000,000        
      net trading losses
    		                                  
      loss (income) and (gain) from sale of equity method investments
    		                                  
      funding and purchase of mortgage loans
    		                                  
      proceeds from sale of business
    		                                  
      change in credit card receivables
    		                                  
      consolidated statements of cash flows (continued) ameriprise financial, inc.
    		                                  
      investment certificates and banking time deposits:
    		                                  
      change in other banking deposits
    		                                200,000,000 149,000,000 
      interest paid before consolidated investment entities
    		                           46,000,000 34,000,000 55,000,000 35,000,000 38,000,000 58,000,000 37,000,000 
      non-cash financing activity:
    		                                  
      dividends declared but not paid
    		                                  
      net unrealized trading losses
    		                               1,000,000   
      loss (income) and gain from sale of equity method investments
    		                                  
      proceeds from sales, maturities and repayments of commercial mortgage loans
    		                            78,000,000 72,000,000 79,000,000 62,000,000 89,000,000 46,000,000 
      funding of commercial mortgage loans
    		                                  
      proceeds from sales of other investments
    		                            48,000,000 133,000,000 67,000,000 38,000,000 45,000,000 53,000,000 
      change in consumer loans
    		                            52,000,000 41,000,000 50,000,000    
      ameriprise financial, inc. consolidated statements of cash flows
    		                                  
      consideration received
    		                            371,000,000 346,000,000 303,000,000 334,000,000 356,000,000 392,000,000 
      future policy benefits and claims
    		                               235,000,000 -225,000,000 294,000,000 
      policyholder and contractholder account values:
    		                                  
      derivatives collateral
    		                                  
      deferred premium options
    		                                  
      income taxes paid (received)
    		                              10,000,000    
      net income of consolidated investment entities
    		                               34,000,000   
      change in consumer banking loans and credit card receivables
    		                                  
      net income (income) attributable to noncontrolling interests
    		                                  
      changes in operating assets and liabilities before consolidated investment entities:
    		                                  
      changes in operating assets and liabilities of consolidated investment entities
    		                                 14,000,000 
      restricted and segregated cash
    		                                  
      change in deferred acquisition costs
    		                                  
      trading securities and equity method investments
    		                                  
      acquisitions
    		                                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.